Every 10-Q that Lightwave Logic, Inc. (LWLG) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-Q covers the quarterly report filed between annual reports, so if you follow LWLG and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full LWLG filings page.
Lightwave Logic, Inc. is an early-stage electro‑optic polymer materials company that began commercial operations in 2023 and remains in a pre‑volume revenue phase. For the quarter ended June 30, 2026, it generated net sales of $32,751, all from a single Swiss customer under a material supply and license agreement.
The company posted a quarterly net loss of $6.6 million and a six‑month net loss of $12.9 million, driven by heavy investment in research and development ($7.4 million year‑to‑date) and general and administrative costs ($6.7 million). Losses widened year over year as headcount, stock‑based compensation, professional services, and wafer fabrication activity increased.
Liquidity strengthened through equity offerings and an at‑the‑market program. As of June 30, 2026, cash and cash equivalents were $47.2 million with marketable securities of $48.7 million, supporting total assets of $108.1 million and no debt. Management states that existing cash, cash equivalents and marketable securities are sufficient to fund operations through at least December 2027, while customer programs progress toward potential production revenues, which are not expected in meaningful volume before 2027.
Lightwave Logic, Inc. reports Q1 2026 results with net sales of $29,167 from its initial polymer material supply and license agreement, up from $22,917 a year earlier, and a net loss of $6,300,540, or $0.04 per share. Research and development expenses rose to $3,490,295 and general and administrative expenses to $3,262,866, driven by higher headcount, stock-based compensation, and development activity. The company ended the quarter with $75,102,750 in cash and cash equivalents and total assets of $85,913,064, stating this cash position is expected to fund operations at least through December 2027. Management continues to focus on commercializing its Perkinamine electro‑optic polymer platform via material sales, licensing, and joint development, and does not yet rely on high-volume production revenue.
Lightwave Logic, Inc. filed an amended quarterly report for the period ended June 30, 2025 to correct how it accounted for certain non-cash stock option exercises. The restatement reduced non-cash compensation expense by $705,499 for the quarter and six-month period, lowering the reported net loss to $4,966,633 for the quarter and $9,663,657 for six months. A separate historical error from 2021 reclassified $3,407,443 between accumulated deficit and additional paid-in capital, without changing cash. The company’s business remains early-stage, with net sales of only $25,605 in the quarter, driven by a single material supply and license agreement.
Lightwave ended the half year with cash and cash equivalents of $22,106,946 and no debt, and expects to spend about $1,786,000 per month over the next 12 months. Management believes existing cash plus two equity facilities totaling up to $60,000,000 in committed purchase and at-the-market programs can fund operations through October 2026, as it continues heavy investment in research and development of its electro‑optic polymer technology.
Lightwave Logic (LWLG) filed its Q3 2025 10‑Q, showing modest net sales and continued investment in R&D as it advances electro‑optic polymer commercialization. Net sales were $29,166 for the quarter and $77,688 year‑to‑date. The company reported a net loss of $5,100,559 for the quarter, or $(0.04) per share.
Quarterly operating expenses included R&D $2,917,473 and G&A $2,290,839. Cash and cash equivalents were $34,942,070 as of September 30, 2025. Net cash used in operating activities was $10,436,426 for the nine months. The company noted expected expenditures of approximately $2,200,000 per month and stated its cash position finances operations through March 2027.
To support liquidity, during the quarter LWLG raised equity via its programs: 4,673,694 shares sold under the ATM for $13,870,294 in proceeds and 1,250,000 shares to an institutional investor for $2,318,505. Remaining capacities disclosed include $26,762,995 under the March 2025 purchase agreement and $12,235,261 under the ATM. Shares outstanding were 132,705,151 as of September 30, 2025.